Obesity & Weight Management Devices Market Growth with Worldwide Industry Analysis to 2021

Obesity is a condition where high density of fatty tissue is observed in the body that directly results in a person being overweight by 20% than standard values. These values calculated through a body mass index or BMI help in identifying and monitoring obesity. The system is extremely beneficial and can be used across people from all regions although many consider it only as a rudimentary tool. A body can be overweight due to excess muscle, fat, bone density or water; however obesity is directly dependent on the amount of accumulated fat in the body.

There are several threats of obesity to the body. It is directly linked to most cardiovascular disorders such as myocardial infarction, stroke, atherosclerosis, hypertension, sleep apnea and some respiratory disorders, gall bladder disease and diabetes along with several mental disorders such as clinical depression, anxiety, lethargy and generally a low quality of life. Obesity is also linked to cancers of gall bladder, liver, breast and colon. Obesity has increased rampantly through the years among adults and especially among children. Among children, obesity can become the reason for lack of social life, derision and can result in severe depression. In United States over one-third of the population (36.5%) continues to be grouped as obese with a significant portion being morbidly obese. Other regions where obesity is on the rise include countries such as Brazil, China and India along with Middle-East countries. Obesity rates in countries such as United Arab Emirates have doubled. Data from the International Diabetes Federation to mark World Diabetes Day in November last year showed that there were 803,900 diabetics in the UAE, about 19 per cent of the population. Studies show that in developed countries such as United States the rate of morbidly obese people requiring surgical intervention may be as high as 6%.

Free Sample Report@ http://www.sa-brc.com/Global-Obesity--Weight-Management-Devices-Market-Assessment--Forecast-2017-2021/up72

SA-BRC will present the market for therapeutic obesity & weight management devices across three categories of weight-groups; clinically obese, obese and overweight. The analysis encompasses several of the popular surgical procedures and devices gastric bands, electrical stimulation systems, lap bands, gastric balloons, endobarrier and gastric emptying systems such as Aspire Assist. These devices are stringently regulated by the U.S. FDA. The report will also provide data on the assessment of the global obesity & weight management devices market size by other surgical procedures such as gastric bypass, biliopancreatic diversion surgeries and incisionless procedures such as StomaphyX. This report also covers weight management devices for overweight category. These devices may or may not be FDA regulated such as ultrasound devices, infra-red devices, vibration based fat burners among others.

The obesity & weight management devices market is fragmented in terms of players in the weight loss and weight management category and is consolidated for the bariatric surgery and obesity treatment devices segment. Key players in this area include Allergan Inc, Medtronic Inc (Covidien), Intuitive Surgical Inc, Johnson & Johnson, GI Dynamics, TransEnterix Inc., Orbera, ReShape, USGI Medical Inc., Semiled Ltd., Cousin Biotech, and Mediflex Surgical Procedures. Several new innovative devices are being introduced by players such as Obalon Therapeutics and Redustim. The market for obesity & weight management looks highly promising even with competition from unconventional avenues of therapies such as herbal and eastern weight loss remedies.

Click For TOC@ http://www.sa-brc.com/Global-Obesity--Weight-Management-Devices-Market-Assessment--Forecast-2017-2021/upcomingdetail72

About Us
Spearhead Acuity Business Research & Consulting Private Limited (SA-BRC) is a premium Life Science business intelligence and data analytics firm. SA-BRC team offers a wide range of business intelligence services to multiple stakeholders such as Medical Device Manufacturers, Service Providers (Hospitals, Payers, etc.), Suppliers, Group Purchase Organizations, Distributors and all other individuals in the entire value chain of healthcare industry. Our research and consulting capabilities extend across several sub-domains within the sphere of Life Sciences such as Biotechnology, Healthcare IT, Medical Devices, Veterinary Sciences, Wellness Products and Pharmaceuticals.

Contact Us
John Whitmore
10685-B Hazelhurst Drive,
Suite 17411
Houston, Texas 77043,
United States
Phone: +1(832)-426-3701
Email: sales@sa-brc.com
Website: www.sa-brc.com

This release was published on openPR.